These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 23769819)
1. Lung function after allogeneic hematopoietic stem cell transplantation in children: a longitudinal study in a population-based cohort. Uhlving HH; Bang CL; Christensen IJ; Buchvald F; Nielsen KG; Heilmann CJ; Müller KG Biol Blood Marrow Transplant; 2013 Sep; 19(9):1348-54. PubMed ID: 23769819 [TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
3. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Uderzo C; Pillon M; Corti P; Tridello G; Tana F; Zintl F; Nysom K; Galambrun C; Fagioli F; Varotto S; Messina C; Verdeguer A; Urban C; Faraci M; Dini G; Fedeli S; Tichelli A; Rovelli A; Socié G Bone Marrow Transplant; 2007 Jun; 39(11):667-75. PubMed ID: 17401396 [TBL] [Abstract][Full Text] [Related]
4. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia]. Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125 [TBL] [Abstract][Full Text] [Related]
5. Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India. Choudhary D; Sharma SK; Gupta N; Kharya G; Pavecha P; Handoo A; Setia R; Katewa S Biol Blood Marrow Transplant; 2013 Mar; 19(3):492-5. PubMed ID: 23160007 [TBL] [Abstract][Full Text] [Related]
6. Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. Savani BN; Montero A; Srinivasan R; Singh A; Shenoy A; Mielke S; Rezvani K; Karimpour S; Childs R; Barrett AJ Biol Blood Marrow Transplant; 2006 Dec; 12(12):1261-9. PubMed ID: 17162207 [TBL] [Abstract][Full Text] [Related]
7. Donor lymphocyte infusion may reduce the incidence of bronchiolitis obliterans after allogeneic stem cell transplantation. Forslöw U; Mattsson J; Gustafsson T; Remberger M Biol Blood Marrow Transplant; 2011 Aug; 17(8):1214-21. PubMed ID: 21193056 [TBL] [Abstract][Full Text] [Related]
8. Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group. Schetelig J; Thiede C; Bornhauser M; Schwerdtfeger R; Kiehl M; Beyer J; Sayer HG; Kroger N; Hensel M; Scheffold C; Held TK; Hoffken K; Ho AD; Kienast J; Neubauer A; Zander AR; Fauser AA; Ehninger G; Siegert W; J Clin Oncol; 2003 Jul; 21(14):2747-53. PubMed ID: 12860954 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation. Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334 [TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study. Remberger M; Mattsson J; Hassan Z; Karlsson N; LeBlanc K; Omazic B; Okas M; Sairafi D; Ringdén O Bone Marrow Transplant; 2008 Feb; 41(4):399-405. PubMed ID: 17982493 [TBL] [Abstract][Full Text] [Related]
12. Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation. El-Cheikh J; Vazquez A; Crocchiolo R; Furst S; Calmels B; Castagna L; Lemarie C; Granata A; Ladaique P; Oudin C; Faucher C; Chabannon C; Blaise D Am J Hematol; 2012 Dec; 87(12):1074-8. PubMed ID: 22911907 [TBL] [Abstract][Full Text] [Related]
13. Bronchiolitis obliterans following pediatric allogeneic hematopoietic stem cell transplantation. Duncan CN; Buonanno MR; Barry EV; Myers K; Peritz D; Lehmann L Bone Marrow Transplant; 2008 Jun; 41(11):971-5. PubMed ID: 18297116 [TBL] [Abstract][Full Text] [Related]
14. Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Bruno B; Gooley T; Sullivan KM; Davis C; Bensinger WI; Storb R; Nash RA Biol Blood Marrow Transplant; 2001; 7(3):154-62. PubMed ID: 11302549 [TBL] [Abstract][Full Text] [Related]